1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Morphea: new trials by email Literature Review of Morphea trials Research Report on Morphea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea) FCX-013, veledimex - Morphea, Scleroderma, Localized | Phase 1 / Phase 2 | Terminated | Castle Creek Biosciences, LLC. | 1 | 2019-12-18 | 2024-01-23 |
Scleroderma, Diffuse (1) · Scleroderma, Localized (1)
Connective Tissue Diseases (1) · Scleroderma, Systemic (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Drug Delivery Systems (1) · veledimex (1)
Castle Creek Biosciences, LLC. (1)
United States (1)